ClinicalTrials.Veeva

Menu

Role of Sweetness in Glucose Regulation (STS)

U

University of Illinois at Urbana-Champaign

Status

Unknown

Conditions

Obesity

Treatments

Other: Experimental I- Inhibition
Other: Control- Stimulation
Other: Experimental II- Inhibition
Other: Experimental I- Stimulation
Other: Experimental II- Stimulation
Other: Control - Inhibition
Other: Sensory Evaluation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Data from several studies show that consuming a diet high in low-calorie sweeteners (LCS), mainly in diet sodas, is linked to the same metabolic disorders as consuming a diet high in added sugars, including an increased risk of developing type 2 diabetes. Sweet taste receptors, once thought to be unique to the mouth, have now been discovered in other parts of the body, including the intestine and the pancreas, where they play a role in blood sugar control. These newly identified receptors provide new avenues to explore how LCS may affect metabolism and health. This project is designed to examine the role of sweet taste signaling, both in the mouth and in the gut, on blood sugar control and how habitual consumption of LCS may affect sweet taste signaling and metabolism in people with obesity.

Full description

The overall goal of this research is to assess the role of oral and gut sweetness signaling in postprandial glucose metabolism and to determine how acute and chronic low-calorie sweetener (LCS) consumption may affect this signaling in people with obesity. The aims will determine the independent and combined contributions of pharmacological inhibition (Aim 1) or extra stimulation (Aim 2) of sweet taste signaling in the gut, mouth, or both on hormonal responses to an oral glucose tolerance test (OGTT) in two groups of subjects with obesity: habitual and non-habitual LCS consumers. Validated sensory evaluation techniques will also ascertain subjects' taste perception (Aim 3) to test the hypotheses that habitual consumption of LCS blunts perception of sweetness and, in turn, affects postprandial glucose regulation.

Enrollment

80 estimated patients

Sex

All

Ages

21 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All races/ethnicities
  • Habitual (> 5 diet sodas per week) and non-habitual (≤1 diet soda or 1 packet of LCS per week) LCS consumers
  • 30 ≤ BMI <40 kg/m2
  • Not severely insulin resistant (HOMA-IR2 < 2.6)

Exclusion criteria

  • BMI < 30 and 40< BMI kg/m2
  • HOMA-IR2>2.6
  • Irregular LCS consumers (>1 diet sodas or packets of LCS per week but <5)
  • Current smokers or quit smoking nicotine cigarettes for less than 6 months ago
  • Pregnant, breastfeeding, menopausal
  • Presence of anemia : <12g/dl for women and <13g/dl for men
  • Blood donation in the past 8 weeks
  • Presence of malabsorption syndrome
  • History of bariatric surgery
  • Presence of inflammatory intestinal disease, liver or kidney disease
  • Have diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucose challenge >200 mg/dl)
  • Taking any medication that might affect glucose metabolism or the results of our study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Inhibition Group
Other group
Description:
Randomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Treatment:
Other: Sensory Evaluation
Other: Experimental I- Inhibition
Other: Control - Inhibition
Other: Experimental II- Inhibition
Stimulation Group
Other group
Description:
Randomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Treatment:
Other: Control- Stimulation
Other: Experimental I- Stimulation
Other: Sensory Evaluation
Other: Experimental II- Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Marta Y Pepino, PhD; Clara Salame, MSc, RD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems